| Product Code: ETC11626077 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite a decline in the CAGR and growth rate in the colorectal cancer drugs market in Nigeria, the country continued to import a significant amount of therapeutic drugs in 2024. The top exporting countries to Nigeria included India, China, Netherlands, Metropolitan France, and the USA, indicating a diverse source of imports. However, the high concentration of the Herfindahl-Hirschman Index (HHI) suggests a market dominated by a few key players. It will be crucial to monitor market dynamics and explore strategies to stimulate growth and improve access to these vital medications for colorectal cancer patients in Nigeria.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Colorectal Cancer Drugs Therapeutic Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Colorectal Cancer Drugs Therapeutic Market - Industry Life Cycle |
3.4 Nigeria Colorectal Cancer Drugs Therapeutic Market - Porter's Five Forces |
3.5 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Nigeria Colorectal Cancer Drugs Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of colorectal cancer in Nigeria |
4.2.2 Rising awareness about colorectal cancer screening and treatment options |
4.2.3 Adoption of advanced therapeutic drugs for colorectal cancer |
4.3 Market Restraints |
4.3.1 High cost of colorectal cancer drugs |
4.3.2 Limited access to advanced treatment facilities in certain regions of Nigeria |
5 Nigeria Colorectal Cancer Drugs Therapeutic Market Trends |
6 Nigeria Colorectal Cancer Drugs Therapeutic Market, By Types |
6.1 Nigeria Colorectal Cancer Drugs Therapeutic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.4 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.5 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Nigeria Colorectal Cancer Drugs Therapeutic Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.2.5 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.2.6 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Nigeria Colorectal Cancer Drugs Therapeutic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.3.3 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.3.4 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Nigeria Colorectal Cancer Drugs Therapeutic Market Import-Export Trade Statistics |
7.1 Nigeria Colorectal Cancer Drugs Therapeutic Market Export to Major Countries |
7.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Imports from Major Countries |
8 Nigeria Colorectal Cancer Drugs Therapeutic Market Key Performance Indicators |
8.1 Number of colorectal cancer cases diagnosed annually |
8.2 Rate of adoption of new therapeutic drugs for colorectal cancer |
8.3 Percentage of healthcare facilities offering colorectal cancer treatment and screening services |
9 Nigeria Colorectal Cancer Drugs Therapeutic Market - Opportunity Assessment |
9.1 Nigeria Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Nigeria Colorectal Cancer Drugs Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Nigeria Colorectal Cancer Drugs Therapeutic Market - Competitive Landscape |
10.1 Nigeria Colorectal Cancer Drugs Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Colorectal Cancer Drugs Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |